We provide you with 20 years of free, institutional-grade data for MRSN stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of MRSN. Explore the full financial landscape of MRSN stock.
Total insider purchase within 3 month on this page: $0
Total insider selling within 3 month on this page: -$0
| Name | Action | Shares | Avg Price | Amount | Reported Date |
|---|---|---|---|---|---|
| Mandelia Ashish | Sale | -5,025 | $2.71 | $13,618 | 2024-01-17 |
| Mandelia Ashish | Derivatives Exercise | 12,780 | 2024-01-17 | ||
| Mandelia Ashish | RSU | 12,780 | 2024-01-17 | ||
| Lowinger Timothy B | Sale | -10,409 | $2.71 | $28,208 | 2024-01-17 |
| Lowinger Timothy B | Derivatives Exercise | 29,375 | 2024-01-17 | ||
| Lowinger Timothy B | RSU | 29,375 | 2024-01-17 | ||
| Protopapas Anna | Sale | -29,399 | $2.71 | $79,671 | 2024-01-17 |
| Protopapas Anna | Derivatives Exercise | 86,958 | 2024-01-17 | ||
| Protopapas Anna | RSU | 86,958 | 2024-01-17 | ||
| MISRA TUSHAR | Sale | -3,357 | $2.71 | $9,097 | 2024-01-17 |
| MISRA TUSHAR | Derivatives Exercise | 8,541 | 2024-01-17 | ||
| MISRA TUSHAR | RSU | 8,541 | 2024-01-17 | ||
| Carvajal Alejandra | Sale | -4,381 | $2.71 | $11,873 | 2024-01-17 |
| Carvajal Alejandra | Derivatives Exercise | 11,458 | 2024-01-17 | ||
| Carvajal Alejandra | RSU | 11,458 | 2024-01-17 | ||
| DeSchuytner Brian | Sale | -9,327 | $2.71 | $25,276 | 2024-01-17 |
| DeSchuytner Brian | Derivatives Exercise | 26,458 | 2024-01-17 | ||
| DeSchuytner Brian | RSU | 26,458 | 2024-01-17 | ||
| Bala Mohan | Sale | -3,431 | $2.71 | $9,298 | 2024-01-17 |
| Bala Mohan | Derivatives Exercise | 8,750 | 2024-01-17 | ||
| Bala Mohan | RSU | 8,750 | 2024-01-17 | ||
| Dere Willard H | Grant, award...etc | 6,112 | 2024-01-04 | ||
| MOTT DAVID M | Grant, award...etc | 8,810 | 2024-01-04 | ||
| Bala Mohan | Sale | -1,912 | $1.13 | $2,161 | 2023-10-27 |
| Bala Mohan | Derivatives Exercise | 6,250 | 2023-10-27 | ||
| Bala Mohan | RSU | 6,250 | 2023-10-27 | ||
| Dere Willard H | Grant, award...etc | 11,011 | 2023-10-04 | ||
| MOTT DAVID M | Grant, award...etc | 15,873 | 2023-10-04 | ||
| Protopapas Anna | Grant, award...etc | 16,643 | 2023-09-13 | ||
| Bala Mohan | Initial | 2023-09-07 | |||
| MISRA TUSHAR | Sale | -1,908 | $1.18 | $2,251 | 2023-08-18 |
| MISRA TUSHAR | Derivatives Exercise | 6,250 | 2023-08-18 | ||
| MISRA TUSHAR | RSU | 6,250 | 2023-08-18 | ||
| Dere Willard H | Grant, award...etc | 4,217 | 2023-07-06 | ||
| MOTT DAVID M | Grant, award...etc | 6,079 | 2023-07-06 | ||
| Alleva Lawrence M | Grant, award...etc | 14,467 | 2023-06-12 | ||
| Dere Willard H | Grant, award...etc | 14,467 | 2023-06-12 | ||
| Diaz Allene M. | Grant, award...etc | 14,467 | 2023-06-12 | ||
| Hege Kristen | Grant, award...etc | 14,467 | 2023-06-12 | ||
| MOTT DAVID M | Grant, award...etc | 14,467 | 2023-06-12 | ||
| Huber Martin H. Jr. | Grant, award...etc | 14,467 | 2023-06-12 | ||
| Hack Andrew A. F. | Grant, award...etc | 14,467 | 2023-06-12 | ||
| Carvajal Alejandra | Sale | -3,944 | $3.89 | $15,342 | 2023-04-28 |
| Carvajal Alejandra | Derivatives Exercise | 13,250 | 2023-04-28 | ||
| Carvajal Alejandra | RSU | 13,250 | 2023-04-28 | ||
| MOTT DAVID M | Grant, award...etc | 4,866 | 2023-04-05 | ||
| Dere Willard H | Grant, award...etc | 3,375 | 2023-04-05 | ||
| MISRA TUSHAR | Sale | -458 | $5.74 | $2,629 | 2023-01-18 |
| MISRA TUSHAR | Derivatives Exercise | 1,459 | 2023-01-18 | ||
| MISRA TUSHAR | RSU | 1,459 | 2023-01-18 | ||
| DeSchuytner Brian | Sale | -5,131 | $5.74 | $29,452 | 2023-01-18 |
| DeSchuytner Brian | Derivatives Exercise | 16,458 | 2023-01-18 | ||
| DeSchuytner Brian | RSU | 16,458 | 2023-01-18 | ||
| Lowinger Timothy B | Sale | -6,233 | $5.74 | $35,777 | 2023-01-18 |
| Lowinger Timothy B | Derivatives Exercise | 20,001 | 2023-01-18 | ||
| Lowinger Timothy B | RSU | 20,001 | 2023-01-18 | ||
| Carvajal Alejandra | Sale | -782 | $5.74 | $4,489 | 2023-01-18 |
| Carvajal Alejandra | Derivatives Exercise | 2,500 | 2023-01-18 | ||
| Carvajal Alejandra | RSU | 2,500 | 2023-01-18 | ||
| Yang Arvin | Sale | -2,209 | $5.74 | $12,680 | 2023-01-18 |
| Yang Arvin | Derivatives Exercise | 7,084 | 2023-01-18 | ||
| Yang Arvin | RSU | 7,084 | 2023-01-18 | ||
| Mandelia Ashish | Sale | -3,575 | $5.74 | $20,521 | 2023-01-18 |
| Mandelia Ashish | Derivatives Exercise | 10,136 | 2023-01-18 | ||
| Mandelia Ashish | RSU | 10,136 | 2023-01-18 | ||
| Protopapas Anna | Sale | -17,346 | $5.74 | $99,566 | 2023-01-18 |
| Protopapas Anna | Derivatives Exercise | 55,708 | 2023-01-18 | ||
| Protopapas Anna | RSU | 55,708 | 2023-01-18 | ||
| Lowinger Timothy B | Derivatives Exercise | 35,361 | 2022-12-16 | ||
| Yang Arvin | Sale | -5,527 | $6.59 | $36,423 | 2022-12-02 |
| Yang Arvin | Derivatives Exercise | 18,500 | 2022-12-02 | ||
| Yang Arvin | RSU | 18,500 | 2022-12-02 | ||
| MISRA TUSHAR | Sale | -1,879 | $7.1 | $13,341 | 2022-08-18 |
| MISRA TUSHAR | Derivatives Exercise | 6,250 | 2022-08-18 | ||
| MISRA TUSHAR | RSU | 6,250 | 2022-08-18 | ||
| Hack Andrew A. F. | Open Market Purchase | 95,519 | $3.28 | 2022-06-02 | |
| Hack Andrew A. F. | Open Market Purchase | 265,155 | $3.29 | 2022-05-26 | |
| Hack Andrew A. F. | Open Market Purchase | 215,599 | $3.49 | 2022-05-23 | |
| Hack Andrew A. F. | Open Market Purchase | 350,000 | $3.1 | 2022-05-18 | |
| Carvajal Alejandra | Sale | -3,948 | $3.69 | $14,568 | 2022-04-28 |
| Carvajal Alejandra | Derivatives Exercise | 13,250 | 2022-04-28 | ||
| Carvajal Alejandra | RSU | 13,250 | 2022-04-28 | ||
| Hack Andrew A. F. | Open Market Purchase | 617,284 | $4.05 | 2022-04-14 | |
| Hack Andrew A. F. | Open Market Purchase | 598,086 | $4.18 | 2022-04-13 | |
| Hack Andrew A. F. | Open Market Purchase | 1,136,363 | $4.42 | 2022-02-08 | |
| DeSchuytner Brian | Derivatives Exercise | 10,208 | 2022-01-19 | ||
| Lowinger Timothy B | Sale | -4,741 | $5.92 | $28,067 | 2022-01-19 |
| Lowinger Timothy B | Derivatives Exercise | 15,209 | 2022-01-19 | ||
| Mandelia Ashish | Sale | -1,982 | $5.92 | $11,733 | 2022-01-19 |
| Mandelia Ashish | Derivatives Exercise | 5,353 | 2022-01-19 | ||
| Protopapas Anna | Derivatives Exercise | 38,958 | 2022-01-19 | ||
| Hack Andrew A. F. | Open Market Purchase | 815,000 | $6.15 | 2022-01-04 | |
| Hack Andrew A. F. | Open Market Purchase | 875,000 | $5.75 | 2022-01-03 | |
| Lowinger Timothy B | Derivatives Exercise | 45,593 | 2021-12-20 | ||
| Yang Arvin | Sale | -5,527 | $6.81 | $37,639 | 2021-12-02 |
| Yang Arvin | Derivatives Exercise | 18,500 | 2021-12-02 | ||
| Lowinger Timothy B | Sale | -2,216 | $11.01 | $24,398 | 2021-08-24 |
| Lowinger Timothy B | Derivatives Exercise | 2,216 | 2021-08-24 | ||
| Lowinger Timothy B | Sale | -2,227 | $12.11 | $26,969 | 2021-07-22 |
| Lowinger Timothy B | Derivatives Exercise | 2,227 | 2021-07-22 | ||
| Protopapas Anna | Sale | -41,944 | $12.47 | $523,042 | 2021-07-19 |
| Protopapas Anna | Derivatives Exercise | 100,000 | 2021-07-19 |
The information provided in this report about MRSN stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Mersana Therapeutics, Inc(NASDAQ:MRSN) 
Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on the development of antibody drug conjugates (ADC) for cancer patients with unmet need. The company develops XMT-1536, a Dolaflexin ADC targeting NaPi2b that is in Phase I clinical trial for the treatment of patients w...
Website: http://www.mersana.com
Founded: 2001
Full Time Employees: 83
Sector: Healthcare
Industry: Biotechnology